Regulation of intracellular glucocorticoid concentrations
US6838253B2 · kind B2 · utility
30Cited by
1References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 22, 2002 |
| Grant date | Jan 4, 2005 |
| Priority date | — |
| Expiry date | Nov 20, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Therefore, another aspect of the invention is a method for determining whether a compound or composition is a regulator of intracellular glucocorticoid activity in adipose tissue comprising determining whether said compound or composition inhibits reductase activity of 11-Beta-hydroxysteroid dehydrogenase 1 (11-Beta HSD1) in said tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.